Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
---|---|---|
Current Price | $12.48 | $4.34 |
Change | -0.02 (-0.16%) | 0.02 (0.46%) |
Market Cap | $0.96B | $0.20B |
Trailing P/E | 0.00 | 0.00 |
Forward P/E | -4.64 | -7.48 |
Dividend Yield | 0.00% | 0.00% |
52-Week High | $17.00 | $16.11 |
52-Week Low | $6.44 | $3.55 |
Beta | 0.00 | 0.00 |
Earnings Per Share | $-3.07 | $-0.64 |
Processing data. Please try again later.
Average Return
Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
---|---|---|---|---|---|---|
REPL | 34.63% | 5.32% | 26.19% | -44.41% | -17.68% | -17.68% |
YMAB | -1.59% | -29.89% | -62.55% | -89.39% | -81.92% | -81.92% |